D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis

Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder

(2013) Damiaan Denys et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Grand Challenges in Global Mental Health: Integration in Research, Policy, and Practice

(2013) Pamela Y. Collins et al.   PLOS MEDICINE

EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)

(2012) Mehdi Sayyah et al.   DEPRESSION AND ANXIETY

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials

(2012) Markus Dold et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder

(2011) Maria Rosaria A. Muscatello et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder

(2011) Juliana Belo Diniz et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Quetiapine Addition to Serotonin Reuptake Inhibitors in Patients With Severe Obsessive-Compulsive Disorder

(2008) Andreas Kordon et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder

(2008) Daniela Perani et al.   NEUROIMAGE